We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Optimizing the Isolation of Cell-Free DNA From Liquid Biopsy Samples

Diagnostic tests are at the core of medicine. Liquid biopsies in particular are incredibly valuable, giving a more holistic disease profile and making it easier to measure a condition over time.

However, with a liquid biopsy, you only have a limited amount of useful genetic material, for example, only a small amount of cell-free DNA (cfDNA) can be found in the blood stream. Therefore, there is a need for an efficient, highly sensitive technology, such as NGS, to detect these fruitful biomarkers. 


Download this collection of case studies to discover how, using a liquid biopsy sample, you can:

  • Monitor therapeutic response in non-small cell lung cancer
  • Detect cancer-associated mutations and identify therapeutic targets
  • Effectively capture cfDNA with minimal co-purification of higher molecular weight DNA

Brought to you by
Cytiva
Download the Application Note for FREE now!